Biochemistry, Genetics and Molecular Biology
CRISPR
100%
DNA Damage Response
91%
DNA Damage
68%
BRCA1
46%
DNA Repair
40%
DNA Gyrase
34%
Cell Survival
34%
Anticancer
28%
S Phase
25%
Tumor Suppressor Protein
25%
Tumor Progression
24%
Poly ADP Ribose Polymerase
23%
Double-Strand DNA Break
22%
Homologous Recombination
20%
Tumor Suppressor Gene
20%
Ubiquitination
17%
Fibrinogen
17%
Flow Cytometry
17%
Posttranslational Modification
17%
Phosphodiesterase
17%
Proteomics
17%
USP7
17%
Replication Timing
17%
Cell Surface Protein
17%
Independent Pathway
17%
Genetics
17%
Histone
17%
Adenosine Diphosphate Ribose
17%
Immunity
17%
Glycoside Hydrolase
15%
Syngenic
14%
Protein Complexes
12%
Immune Evasion
11%
Proteasome
11%
Programmed Cell Death
10%
Biological Phenomena and Functions Concerning the Entire Organism
10%
Drug Megadose
8%
Non-Homologous End Joining
8%
Cancer Cell
8%
Telomere
8%
Ubiquitin
7%
TOP2A
5%
Type II Topoisomerase
5%
Dynamics
5%
Multiprotein Complex
5%
Tumor Initiation
5%
Interferon
5%
RNA Sequence
5%
Transcriptomics
5%
Keyphrases
CRISPR Interference (CRISPRi)
51%
DNA Damage Response
31%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
23%
Breast Cancer Susceptibility Gene 1 (BRCA1)
21%
53BP1
20%
Synthetic Lethality
20%
Double-strand Breaks
19%
BCL2L1
17%
Post-translational Modification
17%
Regulatory Factors
17%
End Joining
17%
ASF1
17%
Histone Chaperone
17%
FOXK1
17%
Tyrosyl-DNA Phosphodiesterase 1 (TDP1)
17%
Replication Timing
17%
Ubiquitylation
17%
Radiation Therapy
17%
DNA Double-strand Break Repair
17%
Tumor Suppressor
17%
Synthetic Lethal
17%
Isogenic Cells
17%
Vulnerability
17%
Kirrel
17%
Independent Pathway
17%
Topoisomerase II Poison
17%
Etoposide
17%
Radiotherapy
17%
Immunotherapy Targets
17%
Triple-negative Breast Cancer
17%
Protein Complex
13%
Genome Integrity
11%
Topoisomerase II
11%
Immune Evasion
11%
DNA Repair
11%
DNA Damage
11%
Covalent Complex
9%
Homologous Recombination
9%
Cellular Response
9%
Tumor Growth
9%
Double-strand Break Repair
8%
DNA Double-strand Breaks
7%
Cell Survival
7%
IL-1R1
6%
PARP Inhibitor (PARPi)
6%
Loss-of-function Screen
6%
Whole Genome
6%
Signaling Network
5%
Cytotoxic Lesion
5%
DNA Damage Signaling
5%
